| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |